UNSPSC 51341606: Tromantadine hydrochloride

This classification denotes an antiviral agent with the molecular formula C16H28N2O2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H09LUS437B, chemically known as acetamide, n-1-adamantyl-n-(2-(dimethylamino)ethoxy)-, hydrochloride but more generally known as tromantadine hydrochloride, which bears US NIH Compound Identifier 64284. European Medicines Agency schedules Tromantadine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04992MIG.

UNSPSC 51341606 Tromantadine hydrochloride is a Commodity code for a specific antiviral pharmaceutical product, though recent state and local opportunities under this code show limited direct procurement activity aligned with the code's nominal scope. The most recent opportunities tagged to this code involve pharmaceutical warehouse supply contracts and naloxone procurement, which diverge from tromantadine specifically. Tromantadine hydrochloride procurement, when it appears in state and local markets, typically serves public health agencies and emergency preparedness programs seeking antiviral medications for stockpiling or routine distribution. Issuing bodies under pharmaceutical commodity codes of this type include state departments of health and public health, county health departments, and community health systems operating within or on behalf of larger jurisdictions.

Recent activity shows procurement fragmented across health authorities in different states. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for antibiotic products, while Seminole County, Florida released an IFB (IFB60459723LAS) in June 2026 for naloxone and drug deactivation systems with a response deadline of July 26, 2023. Neither opportunity explicitly names tromantadine hydrochloride as a line item; both are tagged to the code but center on different pharmaceutical products. The divergence between code taxonomy and actual buying patterns suggests this Commodity code sees limited direct solicitation activity, or that state and local buyers are tagging related pharmaceutical acquisitions under a single code family despite product-level variation. No open, active solicitations for tromantadine hydrochloride itself appear in the recent-opportunities block.